Zosano Pharma

Zosano Pharma, a biopharmaceutical company, develops products based on the transdermal delivery technology.

Zosano Pharma is a private pharmaceutical company founded in October 2006 and is focused on creating better products with their innovative drug delivery technology. Their lead program, parathyroid hormone (PTH) transdermal microprojection delivery system has finalized a Phase 2 clinical trial for treating severe osteoporosis. Zosano's objective is to discover and develop therapeutic drug candidates which address large unmet medical needs or have a significant potential for commercialization.